LevineM, FrobergB, RuhaAM, Burns-EwaldM, YenM, ClaudiusIA, ArthurAO, TormoehlenL, ThomasSH: Assessing the toxicity and associated costs among pediatric patients admitted with unintentional poisonings of attention-deficit/hyperactivity disorder drugs in the United States. Clin Toxicol (Phila), 51:147–150, 2013.
2.
Lexicomp Online: Pediatric & Neonatal Lexi-Drugs Online™. Hudson, OH: Lexicomp, Inc., Available at http://online.lexi.com/lco/action/doc/retrieve/docid/pdh_f/128784#phk accessed May20, 2014.
3.
McGrathJC, Klein-SchwartzW: Epidemiology and toxicity of pediatric guanfacine exposures. Ann Pharmacother, 36:1698–1703, 2002.
4.
MinnsAB, ClarkRF, SchneirA: Guanfacine overdose resulting in initial hypertension and subsequent delayed, persistent orthostatic hypotension. Clin Toxicol (Phila), 48:146–148, 2010.
5.
National Heart, Lung, and Blood Institute: Blood Pressure Tables for Children and Adolescents from the Fourth Report on the Diagnosis, Evaluation and Treatment of High Blood Pressure in Children and Adolescents, 2004. Available at http://www.nhlbi.nih.gov/guidelines/hypertension/child_tbl.pdf. Accessed September14, 2013.
6.
National Institutes of Health Consensus Development Conference Statement: Diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD). J Am Acad Child Adolesc Psychiatry, 39:182–193, 2000.
7.
PaulozziLJ. Prescription drug overdoses: A review. J Safety Res, 43:283–289, 2012
8.
SalleeFR, McgoughJ, WigalT, DonahueJ, LyneA, BiedermanJ, for the SPD503 Study Group: Guanfacine extended release in children and adolescents with attention- deficit/hyperactivity disorder: A placebo-controlled trial. J Am Acad Child Adolesc Psychiatry, 48:155–165, 2009.
9.
TszeDS, DayanPS: Treatment of guanfacine toxicity with naloxone. Pediatr Emerg Care, 28: 1060–1061, 2012.
10.
Van DykeMW, BonaceAL, EllenhornMJ: Guanfacine overdose in a pediatric patient. Vet Hum Toxicol, 32:46–47, 1990.
11.
WilensTE, SpencerTJ: The stimulants revisited. Child Adolesc Psychiatr Clin N Am, 9:573–603, viii, 2000.
